StreetAlpha.app
Home › Stocks › STE

STERIS plc (STE)

Healthcare
$257.35
▼ −1.74%
LAST CLOSE · NOV 17

STERIS makes infection prevention products, sterilizers and sterilization services for healthcare providers and drug and device makers. It last closed at $257.35 on Nov 17, down 1.74% on the day. STE reports earnings on Wed, Feb 3, 2027. The average 12-month price target from 2 analysts is $294.50 (+14.4% from the last close), with a high of $305.00 and a low of $284.00. In the past 30 days there were 5 dark pool prints totaling $8.6M, the largest $5.0M.

AI Auto Pilots
Is STE in one of our four AI portfolios? Sign in free to see

Key Stats

Last 12 months
Results
Revenue
$6.2B
+8.1% vs a year ago
Net income
$826.9M
+20.1% vs a year ago
Free cash flow
$937.2M
15.2% margin
Gross margin
44.6%
$2.7B gross profit
Valuation
Market cap
$25.0B
97.1M shares
P/E
–
Price to sales
4.1
Market cap over revenue
Dividend yield
1.00%
$2.58 a share over 12 months
Balance sheet
Cash & equivalents
$531.1M
At Sep 30
Debt
$1.7B
At Sep 30
Shareholder equity
$7.3B
Buybacks
$340.3M
Last 12 months
Fiscal year endsMarch
ExchangeNYSE
Financials history
FY2022: $4.2B$4.2BFY2022FY2023: $4.5B$4.5BFY2023FY2024: $5.1B$5.1BFY2024FY2025: $5.5B$5.5BFY2025FY2026: $5.9B$5.9BFY2026

From STE's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 5). Last 12 months adds up the four latest quarters.

Next report
Feb 3
2027 · Time not announced
Consensus EPS forecast
$2.80
$1.60B revenue est.
Year-ago EPS
—
Not on file
Options-implied move
—
Posted about a week before
Analyst consensus
2 Buy
2 firms · not enough for a consensus
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Ratings · 90 days
2 Buy
2firms
2 Buy0 Hold0 Sell
Only 2 firms rated STE in the past 90 days, not enough for a consensus
Average 12-month target
$294.50
▲ 14.4% upside

Based on 2 analysts who set a price target on STE in the past 90 days. The average target is $294.50, with a high of $305.00 and a low of $284.00, compared with the last close of $257.35.

Low $284.00Avg $294.50High $305.00
Blue marker: last close $257.35
Highest target$305.00
Average target$294.50
Lowest target$284.00
Latest rating changes
JefferiesUpgrade
Nov 13Buy$305
KeybancMaintained
Nov 6Buy$284
UBSTarget lowered
Aug 7Buy$275 → $270
Piper SandlerReiterated
Aug 7Buy$275
UBSInitiated
Jul 28Buy$275
DateFirmActionRatingPrice target
Nov 13JefferiesUpgradeBuy$305
Nov 6KeybancMaintainedBuy$284
Aug 7UBSTarget loweredBuy$275 → $270
Aug 7Piper SandlerReiteratedBuy$275
Jul 28UBSInitiatedBuy$275
Loading…

Technical Analysis

STE · as of the Nov 17 close · updated after every close
Uptrend, nearing overbought

The stock is 6% above its 20 day and 13% above its 50 day average. It is 13% above its 200 day average, so the longer trend is still up. Momentum is strong (RSI 66), near overbought. The nearest support is the Pivot S1 at $255.34, and the nearest resistance the Pivot at $258.90.

Short trendBullish
Long trendBullish
MomentumStrong
StretchNear overbought
VolatilityHigh, 2.6%/day
Key levels
$269.4452 week high+4.7%
$260.91Pivot R1+1.4%
$259.25Swing high (Nov 5)+0.7%
$258.90Pivot+0.6%
$257.35Last close
$255.34Pivot S1−0.8%
$242.9620 day average−5.6%
$229.36Swing low (Aug 17)−10.9%
$225.09100 day average−12.5%
$224.8050 day average−12.6%
$224.10200 day average−12.9%
$195.1452 week low−24.2%
Indicators
RSI (14)66.12Strong, overbought above 70Neutral
MACD10.43Above its signal lineBullish
Stochastic88.9Near the top of its rangeOverbought
ADX (14)46.6Strong uptrend
Williams %R-22.3Oversold below −80, overbought above −20Neutral
CCI (20)84.0Oversold below −100, overbought above 100Neutral
Rate of change+11.3%Change over 10 sessionsBullish
ATR (14)$6.66Typical daily range, 2.6% of price
MA 10Above
MA 20Above
MA 50Above
MA 100Above
MA 200Above
What happened before, for STE

What happened before

See how STE did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.

November seasonalityHow STE usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

Seasonality

How STE has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2006.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D

No whale options trades in STE in the last 90 days.

Loading…

See today’s whale options flow across the market →

Dark Pool

30D
Prints
5
Notional
$8.6M
Largest print
$5.0M
Loading…

STE Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Neutral
Strongly bearishNeutralStrongly bullish
  • ●377 buying vs 380 selling
  • ▼Held by funds -0.5 pts
  • ▼Funds holding -19
  • ▲Superinvestors: 4 added, 1 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding817836−2.3%
In funds' top 1045−20.0%
Held by funds97.5%98.0%−0.5 pts
New / increased82 / 29596 / 300−4.8%
Reduced / sold out288 / 92303 / 103−6.4%
Put/call ratio1.480.35+321.9%
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See STE institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

STE Stock Buybacks

See all S&P 500 buybacks →
Spent, 12 months
$340.3M
1.4% yield
Left in program
$800.0M
3.2% of value
Shares outstanding, 12 months
−1.1%
Fewer shares
Last quarter
$94.2M
Sep 2026
Avg price paid, last quarter
$235.46
400K shares bought
S&P 500 rank by spending
#304 of 358
 
Spent each quarter, last 3 yearsTop bar $100.0M
Dec 2023: $0Mar 2024: $0Jun 2024: $56.1M, average price $223.15Sep 2024: $43.9M, average price $224.83Dec 2024: $100.0M, average price $217.16Mar 2025: $0Jun 2025: $0Sep 2025: $98.6M, average price $246.59Dec 2025: $52.3M, average price $261.71Mar 2026: $73.9M, average price $246.40Jun 2026: $85.7M, average price $214.25Sep 2026: $94.2M, average price $235.46
Dec 2023Sep 2026
For membersMonth by month buying, shares and the average price paid each month are shown to AI Starter and AI Pro members.

From the company's 10-Q filed Nov 5, 2026. Quarters are the company's own fiscal quarters. Yield and % of value use the latest close. Buybacks are not a forecast: in our testing, the biggest buyers did about the same as the average S&P 500 stock.

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether STE is in one of them and how their past STE trades turned out.

STE in the AI portfolios
Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered STE in an article yet. Here's the latest on the wider market.

STE Congress Trades

All congress trades →
Trades, 12 months
26
Buys
15
58%
Sells
11
42%
People
7
Last filed Nov 5
Who traded STE · since 2014
Latest 5 filings of 55
$1K – $15KTraded Oct 7, 2026Filed Nov 5, 2026
$1K – $15KTraded Sep 25, 2026Filed Oct 7, 2026
$1K – $15KTraded Sep 11, 2026Filed Oct 7, 2026
$15K – $50KTraded Sep 15, 2026Filed Sep 28, 2026
$1K – $15KTraded Jul 8, 2026Filed Sep 22, 2026
PersonTypeAmountTradedFiledDelay
Ro KhannaD · CASell$1K – $15KOct 7, 2026Nov 5, 202629 d
Ro KhannaD · CASell$1K – $15KSep 25, 2026Oct 7, 202612 d
Ro KhannaD · CABuy$1K – $15KSep 11, 2026Oct 7, 202626 d
Kevin HernR · OKSell$15K – $50KSep 15, 2026Sep 28, 202613 d
Donald J TrumpExecutive branchSell$1K – $15KJul 8, 2026Sep 22, 202676 d

Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.

About STERIS

STERIS provides infection prevention products and services for patient care, based in Dublin, Ireland. Its offerings include cleaning chemistries, sterilizers, endoscopy accessories, surgical tables, and maintenance and repair services for hospitals and procedure centers. The company also runs contract sterilization and laboratory testing for medical device and pharmaceutical manufacturers, and supplies cleanroom products and sterilization equipment to biopharmaceutical plants. Its customers include healthcare providers, medical device makers and drug manufacturers around the world.

Headquarters
Dublin, Ireland
Founded
1985